期刊文献+

人参皂甙Rg3在小鼠肝癌淋巴结转移模型中诱导细胞凋亡的作用 被引量:28

Role of Ginsenoside Rg3 in inducing Apoptosis of Tumor Cells in the Lymphatic Metastasis Mouse
下载PDF
导出
摘要 目的:观察人参皂甙Rg3对小鼠肝癌淋巴结转移模型中肿瘤细胞凋亡的诱导作用,探讨人参皂甙Rg3抗肿瘤淋巴结转移的机制。方法:建立小鼠肝癌淋巴结转移模型;光镜和透射电镜下观察各组(Rg3预防组、Rg3治疗组、Rg3与顺铂联合治疗组、顺铂治疗组及对照组)中原发瘤及转移瘤组织的形态学结构改变,并通过流式细胞仪分析肿瘤细胞的凋亡。结果:Rg3预防组及治疗组电镜下(5份样品)可见较多细胞凋亡小体的形成(5/5,4/5);顺铂治疗组的形态改变以细胞破坏为主,凋亡的细胞较少;联合治疗组细胞的凋亡和坏死程度相当。流式细胞学检测分析结果为:Rg3预防组、治疗组及联合治疗组均见细胞凋亡的特征峰(5/5),而顺铂治疗组为1/5,对照组未见凋亡峰(0/5)。结论:人参皂甙Rg3抗肿瘤细胞淋巴结转移的作用与诱导细胞凋亡有关。 Objective: To study the mechanism of Ginshenoside Rg3 in anti-lymphatic metastasis of hepatoma by the observation of the apoptosis effect which may be induced in mouse. Methods: The transplanted hepatoma models with lymphatic metastasis were set up, and the apoptosis of the primary and metastatic tumors was analysed in the following five groups: Ginsenoside Rg3 pretreatment, Ginsenoside Rg3 treatment, combination of Ginsenoside Rg3 & cisplatin treatment, cisplatin treatment and control (saline) groups. Results: The morphologic change under the light and electric miocroscope showed that more apoptosis bodies appeared in Ginsenoside Rg3 pretreatment and Ginsenoside Rg3 treatment groups compared with those of the other groups (5/5, 4/5); The extent of cell necrosis in cisplatin treatment group was more obvious; while the apoptosis and cell necrosis presenting in combination group in between. Apoptosis peak was observed by FCM and apoptosis nodule was detected in Ginsenoside Rg3-treated groups; The main change in the control group was cell injury, and no apoptosis peak detected. Conclusion: Apoptosis is one of the mechanisms of Ginsenoside Rg3 in volving its the anti-lymphatic metastasis effect.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2004年第19期1120-1122,共3页 Chinese Journal of Clinical Oncology
关键词 治疗组 人参皂甙RG3 淋巴结转移 鼠肝 肝癌 细胞凋亡 顺铂 诱导 镜下观察 流式细胞仪分析 Ginsenoside Rg3 Hepatoma Lymphatic Metastasis Apoptosis
  • 相关文献

参考文献11

二级参考文献33

  • 1凌茂英,王明辉,郭伶伶,王波.HCa/16A3-F及HCa/A2-P两株小鼠淋巴道转移肝癌细胞系的特性研究[J].中华医学杂志,1995,75(3):170-171. 被引量:40
  • 2韩萍.含人参皂甙Rg3的药物可选择性的抑制癌细胞[J].国外医学植物分册,1994,9(2):89-89.
  • 3Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol, 1995; 147(1):9.
  • 4Fan ZN, Isobe K, Kiuchi K oet al. Enhancement of nitric oxide production from activated macrophages by a purified form of ginsenoside (Rg1). Am J Chin Med, 1995; 23(3-4) :279.
  • 5Imamura F, Horai T, Mukai M, et al. Serum requirement for in vitro invasion by tumor cells. Jpn J Cancer Res, 1991; 82(5):493.
  • 6Folkman J. Clinical application of research on angiogenesis.New Engl J Med, 1995; 333(26):1757.
  • 7Thompson WD, William WL, Maragoudakis M, et al. The clinical manipulation of angiogenesis: pathology, slde-effects,surprise and opportunities with novel human therapies. J Pathol, 2000; 190(3) :330.
  • 8Gasparini G, Harris A. Clinical importance of the determination of tumor angiogenesis in breast carcinoma ; much more than a new prognostic tool. J Clin Oncol, 1995; 139(3) :765.
  • 9O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastasis by a Lewis lung carcinoma. Cell, 1994; 79(2):315.
  • 10Slaton JW, Perotte P, Inoue K, et al. Interferon alpha mediated down regulation of angiogenesis related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule. Clin Cancer Res, 1999; 5 (10):2726.

共引文献107

同被引文献275

引证文献28

二级引证文献289

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部